Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Pufei Biotech is a specialized biotechnology company focused on the research, development, and production of high-performance chromatography media for the biopharmaceutical industry. The company offers a comprehensive portfolio of purification resins, including Protein A affinity, ion exchange, and hydrophobic interaction chromatography (HIC) media, which are critical for the downstream processing of biologics. Pufei Biotech serves manufacturers of monoclonal antibodies, recombinant proteins, and vaccines, providing high-quality domestic alternatives to international chromatography brands. Beyond product supply, the company provides technical services such as purification process development and optimization to enhance manufacturing efficiency for its clients. Their mission is to support the biopharma sector with cost-effective and reliable purification solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Pufei Biotech.